Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Missouri 25 trials found
New Search
Filter
Trial Phase
Study Type
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
PHASE2INTERVENTIONAL Houston, Texas
RECRUITING
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study in Patients With Advanced Cancers
PHASE1, PHASE2INTERVENTIONAL Austin, Texas +2 more
RECRUITING
Improving Comprehensive Care of Cancer Patients
NAINTERVENTIONAL Houston, Texas
RECRUITING
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
Abatacept in Immune Checkpoint Inhibitor Myocarditis
PHASE3INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Comprehensive Outcomes for After Cancer Health
NAINTERVENTIONAL Gainesville, Florida +4 more
RECRUITING
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
PHASE1INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Trial of DFP-14927 in Advanced Solid Tumors
PHASE1INTERVENTIONAL Los Angeles, California +1 more
RECRUITING
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Fullerton, California +4 more
RECRUITING
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
PHASE1INTERVENTIONAL Houston, Texas
RECRUITING
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
N/AOBSERVATIONAL Houston, Texas
RECRUITING
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
PHASE1INTERVENTIONAL New York, New York +4 more
RECRUITING
The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts
NAINTERVENTIONAL Houston, Texas
RECRUITING
ATEMPT 2.0: Adjuvant T-DM1 vs TH
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
NAINTERVENTIONAL Houston, Texas
RECRUITING
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
PHASE2INTERVENTIONAL Bethesda, Maryland +2 more
RECRUITING
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
NAINTERVENTIONAL Houston, Texas
RECRUITING
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
PHASE1INTERVENTIONAL Lake Mary, Florida +4 more
RECRUITING
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States
NAINTERVENTIONAL Houston, Texas +2 more
RECRUITING
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NAINTERVENTIONAL Houston, Texas
RECRUITING
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.
N/AOBSERVATIONAL Houston, Texas
RECRUITING
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type